REPORTS

Let’s Pullulate and Expand Your Business

DNA Repair Drugs Market - Global Professional Analysis and Forecast to 2026

Jan 20, 2020  |  199 PAGES  |  REPORT CODE: CMM262459
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide DNA Repair Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.6% during the forecast period.

This report presents the market size and development trends by detailing the DNA Repair Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the DNA Repair Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of DNA Repair Drugs industry and will help you to build a panoramic view of the industrial development.

DNA Repair Drugs Market, By Type:

  • PARP Inhibitors

  • Other

DNA Repair Drugs Market, By Application:

  • Oncological

  • Stroke

Some of the leading players are as follows:

  • Jonsson Comprehensive Cancer Center

  • Johnson & Johnson

  • Bristol Myers Squibb

  • Cambridge University Hospitals NHS Foundation Trust

  • Karyopharm Therapeutics

  • Tesaro

  • GlaxoSmithKline

  • Genentech

  • Georgetown University

  • ARCAGY/ GINECO GROUP

  • National Institutes of Health

  • 4SC AG

  • Jiangsu Hengrui Medicine

  • KuDOS Pharmaceuticals

  • British Columbia Cancer Agency

  • German Breast Group

  • National Health Service

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 DNA Repair Drugs Market: Technology Type Analysis

  • 4.1 DNA Repair Drugs Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 DNA Repair Drugs Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 PARP Inhibitors

    • 4.3.2 Other

5 DNA Repair Drugs Market: Product Analysis

  • 5.1 DNA Repair Drugs Product Market Share Analysis, 2018 & 2026

  • 5.2 DNA Repair Drugs Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 DNA Repair Drugs Market: Application Analysis

  • 6.1 DNA Repair Drugs Application Market Share Analysis, 2018 & 2026

  • 6.2 DNA Repair Drugs Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Oncological

    • 6.3.2 Stroke

7 DNA Repair Drugs Market: Regional Analysis

  • 7.1 DNA Repair Drugs Regional Market Share Analysis, 2018 & 2026

  • 7.2 DNA Repair Drugs Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Jonsson Comprehensive Cancer Center

    • 9.1.1 Jonsson Comprehensive Cancer Center Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Johnson & Johnson

    • 9.2.1 Johnson & Johnson Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Bristol Myers Squibb

    • 9.3.1 Bristol Myers Squibb Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Cambridge University Hospitals NHS Foundation Trust

    • 9.4.1 Cambridge University Hospitals NHS Foundation Trust Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Karyopharm Therapeutics

    • 9.5.1 Karyopharm Therapeutics Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Tesaro

    • 9.6.1 Tesaro Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 GlaxoSmithKline

    • 9.7.1 GlaxoSmithKline Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Genentech

    • 9.8.1 Genentech Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Georgetown University

    • 9.9.1 Georgetown University Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 ARCAGY/ GINECO GROUP

    • 9.10.1 ARCAGY/ GINECO GROUP Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 National Institutes of Health

    • 9.11.1 National Institutes of Health Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 4SC AG

    • 9.12.1 4SC AG Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Jiangsu Hengrui Medicine

    • 9.13.1 Jiangsu Hengrui Medicine Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 KuDOS Pharmaceuticals

    • 9.14.1 KuDOS Pharmaceuticals Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 British Columbia Cancer Agency

    • 9.15.1 British Columbia Cancer Agency Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 German Breast Group

    • 9.16.1 German Breast Group Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 National Health Service

    • 9.17.1 National Health Service Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

 

The List of Tables and Figures (Totals 78 Figures and 139 Tables)

  • Figure PARP Inhibitors DNA Repair Drugs market, 2015 - 2026 (USD Million)

  • Figure Other DNA Repair Drugs market, 2015 - 2026 (USD Million)

  • Figure Oncological market, 2015 - 2026 (USD Million)

  • Figure Stroke market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America DNA Repair Drugs market, by country, 2015 - 2026 (USD Million)

  • Table North America DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table North America DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table North America DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table U.S. DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table U.S. DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Canada DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Canada DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Europe DNA Repair Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Europe DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Europe DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Europe DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table U.K. DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table U.K. DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Germany DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Germany DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table France DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table France DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Italy DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Italy DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Spain DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Spain DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific DNA Repair Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table China DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table China DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Japan DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Japan DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table India DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table India DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Latin America DNA Repair Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Latin America DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Latin America DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Latin America DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Brazil DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Brazil DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Mexico DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Mexico DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Argentina DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Argentina DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table MEA DNA Repair Drugs market, by country, 2015 - 2026 (USD Million)

  • Table MEA DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table MEA DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table MEA DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table South Africa DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table South Africa DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria DNA Repair Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria DNA Repair Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria DNA Repair Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Jonsson Comprehensive Cancer Center Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bristol Myers Squibb Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cambridge University Hospitals NHS Foundation Trust Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Karyopharm Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Tesaro Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Genentech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Georgetown University Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ARCAGY/ GINECO GROUP Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table National Institutes of Health Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table 4SC AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Jiangsu Hengrui Medicine Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table KuDOS Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table British Columbia Cancer Agency Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table German Breast Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table National Health Service Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top